Literature DB >> 11259597

Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation.

R M Melillo1, G M Pierantoni, S Scala, S Battista, M Fedele, A Stella, M C De Biasio, G Chiappetta, V Fidanza, G Condorelli, M Santoro, C M Croce, G Viglietto, A Fusco.   

Abstract

The high-mobility group I (HMGI) nonhistone chromosomal proteins HMGI(Y) and HMGI-C have been implicated in defining chromatin structure and in regulating the transcription of several genes. These proteins have been implicated in adipocyte homeostasis: a severe deficiency of fat tissue is found in mice with targeted disruption of the HMGI-C locus, and lipomagenesis in humans is frequently associated with somatic mutations of HMGI genes. The aim of this study was to examine the role of HMGI(Y) proteins in adipocytic cell growth and differentiation. First, we found that differentiation of the preadipocytic 3T3-L1 cell line caused early induction of HMGI(Y) gene expression. Suppression of HMGI(Y) expression by antisense technology dramatically increased the growth rate and impaired adipocytic differentiation in these cells. The process of adipogenic differentiation involves the interplay of several transcription factors, among which is the CCAAT/enhancer-binding protein (C/EBP) family of proteins. These factors are required for the transcriptional activation of adipocyte-specific genes. We also tested the hypothesis that HMGI(Y) might participate in transcriptional control of adipocyte-specific promoters. We found that HMGI(Y) proteins bind C/EBPbeta in vivo and in vitro. Furthermore, we show that HMGI(Y) strongly potentiates the capacity of C/EBPbeta to transactivate the leptin promoter, an adipose-specific promoter. Taken together, these results indicate that the HMGI(Y) proteins play a critical role in adipocytic cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259597      PMCID: PMC86881          DOI: 10.1128/MCB.21.7.2485-2495.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

Review 1.  Is CCAAT/enhancer-binding protein a central regulator of energy metabolism?

Authors:  S L McKnight; M D Lane; S Gluecksohn-Waelsch
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

2.  Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes.

Authors:  A K Student; R Y Hsu; M D Lane
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

3.  CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes.

Authors:  R J Christy; K H Kaestner; D E Geiman; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

4.  HMG-I/Y, a new c-Myc target gene and potential oncogene.

Authors:  L J Wood; M Mukherjee; C E Dolde; Y Xu; J F Maher; T E Bunton; J B Williams; L M Resar
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids.

Authors:  Z Wu; N L Bucher; S R Farmer
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

6.  Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures.

Authors:  V Giancotti; E Buratti; L Perissin; S Zorzet; A Balmain; G Portella; A Fusco; G H Goodwin
Journal:  Exp Cell Res       Date:  1989-10       Impact factor: 3.905

7.  Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes.

Authors:  R J Christy; V W Yang; J M Ntambi; D E Geiman; W H Landschulz; A D Friedman; Y Nakabeppu; T J Kelly; M D Lane
Journal:  Genes Dev       Date:  1989-09       Impact factor: 11.361

8.  Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y.

Authors:  K R Johnson; D A Lehn; R Reeves
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

9.  Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.

Authors:  Z Cao; R M Umek; S L McKnight
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

Review 10.  CCAAT-enhancer binding protein: a component of a differentiation switch.

Authors:  R M Umek; A D Friedman; S L McKnight
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

View more
  38 in total

1.  The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition.

Authors:  Hatem Zayed; Zsuzsanna Izsvák; Dheeraj Khare; Udo Heinemann; Zoltán Ivics
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

2.  Interferon regulatory factors are transcriptional regulators of adipogenesis.

Authors:  Jun Eguchi; Qing-Wu Yan; Dustin E Schones; Michael Kamal; Chung-Hsin Hsu; Michael Q Zhang; Gregory E Crawford; Evan D Rosen
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

3.  Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis.

Authors:  Ronni Nielsen; Thomas Askov Pedersen; Dik Hagenbeek; Panagiotis Moulos; Rasmus Siersbaek; Eva Megens; Sergei Denissov; Michael Børgesen; Kees-Jan Francoijs; Susanne Mandrup; Hendrik G Stunnenberg
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

4.  High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2).

Authors:  Sabrina Battista; Monica Fedele; Josefina Martinez Hoyos; Francesca Pentimalli; Giovanna Maria Pierantoni; Rosa Visone; Ivana De Martino; Carlo Maria Croce; Alfredo Fusco
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

5.  CBX7 is a tumor suppressor in mice and humans.

Authors:  Floriana Forzati; Antonella Federico; Pierlorenzo Pallante; Adele Abbate; Francesco Esposito; Umberto Malapelle; Romina Sepe; Giuseppe Palma; Giancarlo Troncone; Marzia Scarfò; Claudio Arra; Monica Fedele; Alfredo Fusco
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 6.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

7.  High-mobility group A1 proteins are overexpressed in human leukaemias.

Authors:  Giovanna Maria Pierantoni; Valter Agosti; Monica Fedele; Heather Bond; Irene Caliendo; Gennaro Chiappetta; Francesco Lo Coco; Fabrizio Pane; Maria Caterina Turco; Giovanni Morrone; Salvatore Venuta; Alfredo Fusco
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

8.  HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.

Authors:  Jan Brocher; Benjamin Vogel; Robert Hock
Journal:  BMC Cell Biol       Date:  2010-08-11       Impact factor: 4.241

9.  The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake.

Authors:  Stefania Iiritano; Eusebio Chiefari; Valeria Ventura; Biagio Arcidiacono; Katiuscia Possidente; Aurora Nocera; Maria T Nevolo; Monica Fedele; Adelaide Greco; Manfredi Greco; Giuseppe Brunetti; Alfredo Fusco; Daniela Foti; Antonio Brunetti
Journal:  Mol Endocrinol       Date:  2012-06-28

10.  Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1).

Authors:  Adriana Bianconcini; Angelo Lupo; Silvana Capone; Loredana Quadro; Maria Monti; Diana Zurlo; Alessandra Fucci; Lina Sabatino; Antonio Brunetti; Eusebio Chiefari; Max E Gottesman; William S Blaner; Vittorio Colantuoni
Journal:  Int J Biochem Cell Biol       Date:  2009-04-21       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.